81 – 90 of 185
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2000
-
Mark
Cystatin inhibition of cathepsin B requires dislocation of the proteinase occluding loop. Demonstration by release of loop anchoring through mutation of His110
(
- Contribution to journal › Article
-
Mark
A peptidyl derivative structurally based on the inhibitory center of cystatin C inhibits bone resorption in vitro
(
- Contribution to journal › Article
-
Mark
Expression of an LDL receptor allele with two different mutations (E256K and I402T)
(
- Contribution to journal › Article
- 1999
-
Mark
An individual with a healthy phenotype in spite of a pathogenic LDL receptor mutation (C240F)
(
- Contribution to journal › Article
-
Mark
Modulation of invasive properties of murine squamous carcinoma cells by heterologous expression of cathepsin B and cystatin C
(
- Contribution to journal › Article
-
Mark
Inhibition of mammalian legumain by some cystatins is due to a novel second reactive site
(
- Contribution to journal › Article
-
Mark
Digenic inheritance of a ROM1 gene mutation with a peripherin/RDS or rhodopsin mutation in families with retinitis pigmentosa
(
- Contribution to journal › Article
-
Mark
Expression of a selenomethionine derivative and preliminary crystallographic studies of human cystatin C
(
- Contribution to journal › Article
-
Mark
Decreased metastatic spread in mice homozygous for a null allele of the cystatin C protease inhibitor gene
(
- Contribution to journal › Article
- 1998
-
Mark
Cystatin F is a glycosylated human low molecular weight cysteine proteinase inhibitor
(
- Contribution to journal › Article